A participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous ...
The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...
The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.
It was given to people who had acute surgical pain from either abdominoplasty, also known as a tummy tuck, or bunion surgery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback